drugset / Trial / NCT01336322

Metformin and Sitagliptin in Women With Previous Gestational Diabetes

NCT01336322

RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of the present research is to compare the effects of treatment with metformin and sitagliptin, alone or in association, in women with previous gestational diabetes to evaluate the impact of the two drugs on beta-cell function. The study results may contribute to give a rational approach for future investigations.

Timeline

Start
2011-05
Primary completion
2017-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 850 mg
Comparator Sitagliptin Small molecule 100 mg

Indications